Evaluation of a 5% dexpanthenol‐containing ointment for the treatment of infant irritant diaper dermatitis through the lens of the caregiver—A real‐world data observational study

Author:

Peltier Erwan1ORCID,de Salvo Raffaella1,Ehret Andreas1,Trapp Sonja1,Lakomsky Didier2ORCID,El Shazly Maged A.3

Affiliation:

1. Bayer Consumer Care AG Basel Switzerland

2. Bayer Health Care Division Consumer Care Gaillard France

3. Bayer Pakistan PVT LTD, 21‐C, I.T. Karachi City Sindh Pakistan

Abstract

AbstractBackground and AimsIrritant diaper dermatitis (IDD) is very common in infants and usually managed by the caregiver. Dexpanthenol‐containing ointment (DCO) is a decades‐long established product that has demonstrated efficacy and tolerability in the treatment and prevention of infant IDD in controlled clinical settings. The aim of this study was to evaluate the effectiveness of DCO in the treatment of infant IDD from the perspective of the caregiver by collecting data not explored in clinical trials, such as infant quality of life and the speed of action.MethodsA retrospective observational real‐world data (RWD) study was conducted with French adult caregivers who had used a DCO to treat IDD in their infants within the past 6 months and consented to participate to the study completed a web‐based survey answering questions regarding the severity of their infants' symptoms (intensity/extent of redness and discomfort, rated using Likert scales) before and after DCO application. The speed of onset of symptom relief and product acceptability were also collected.ResultsA total of 500 caregivers of 564 infants completed the survey. Of these, 80% reported that DCO visibly treats IDD. In terms of speed of action, 83% declared that the first signs of symptom relief appeared after 1 day of application and 78% reported full symptom resolution within 2 days of application. Additionally, ≥77% of caregivers agreed that DCO provided overnight relief from the discomfort caused by IDD and reduced sleep disturbance in their children. Finally, 85% of caregivers declared being satisfied with the product overall and considered the product pleasant to use.ConclusionThis evidence from caregivers' experience confirms that DCO can be considered an adequate medication to self‐manage IDD episode as it provides rapid relief of the signs and symptoms of inflammation, while by being pleasant to be use.

Publisher

Wiley

Subject

General Medicine

Reference37 articles.

1. Prevention and treatment of diaper dermatitis

2. Safety evaluation for ingredients used in baby care products: Consideration of diaper rash

3. Irritant diaper dermatitis: best practice management;Atherton D;SelfCare,2015

4. New insights in the skin protective activity of a dexpanthenol containing formula (BEPANTHEN®) in a diaper rash‐like model;Peltier E;J Cosmet Dermatol Sci Appl,2020

5. Clinical correlates with diaper dermatitis;Benjamin L;Pediatrician,1987

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Übersichtsarbeit zu klinischem Bild, Subtypen und Therapie;Wiener Medizinische Wochenschrift;2023-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3